By Jamie Lennox ( August 8, 2024, 7:37 PM BST) -- Sanofi-owned biotech Genzyme Corp. has lost an amended version of its European patent over a stem cell treatment after a group of its rivals proved that a key pillar of the process lacks novelty, according to a ruling published Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.